Historical record - last NADAC effective date: 10/18/2023
Product Information
SILDENAFIL 100 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.2046 per EA under NDC 69097095302. Its NADAC has been published 162 times since Oct 7, 2020.
FDA first approved this application on Mar 2, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097095302
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/18/2023
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207178FDA Approved
3/2/2020
TE Code
AB
On Market Since
7/10/2020
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 100 MG TABLET has been published 162 times since Oct 7, 2020, and over the history we have for it it has declined 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2046 per EA |
|---|---|
| All-time high | $0.3869 (Dec 16, 2020) |
| All-time low | $0.2046 (Oct 18, 2023) |
| Median price | $0.2565 |
| Average price | $0.2738 |
| Largest weekly change | -15.5% (Mar 23, 2022) |
| Weeks tracked | 162 |
| Tracking since | Oct 7, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-2.3%
5Y
-17.4%
All
-42.6%
Last surveyed Nov 8, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SILDENAFIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 100 MG TABLET, manufactured by Cipla USA Inc., is $0.2046 per EA (NDC 69097095302), effective Nov 8, 2023.
How has the price of SILDENAFIL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 100 MG TABLET has declined 42.6%. It has been tracked across 162 weekly CMS publications since Oct 7, 2020.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 100 MG TABLET?
Since Oct 7, 2020, the NADAC for SILDENAFIL 100 MG TABLET has ranged from a low of $0.2046 (Oct 18, 2023) to a high of $0.3869 (Dec 16, 2020), with a median of $0.2565 per EA.
Are there cheaper alternatives to SILDENAFIL 100 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SILDENAFIL 100 MG TABLET, is $0.1319 per EA — about 36% below SILDENAFIL 100 MG TABLET.
Who manufactures SILDENAFIL 100 MG TABLET?
SILDENAFIL 100 MG TABLET (NDC 69097095302) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.